Lenza Pro

Manufacturer
Sola Pharmaceuticals
Effective date
2021-01-12
Label type
HUMAN OTC DRUG LABEL
Version
6
Source
legacy-cache
Hydrated at
2026-08-01 22:56:51

Label at a glance#

ProductLenza Pro
Active ingredientLIDOCAINE, MENTHOL
Label structure12 sections

Label contents#

Full prescribing information#

OTC - ACTIVE INGREDIENT SECTION

Menthol 4%
Lidocaine 4%

OTC - PURPOSE SECTION

Topical Analgesic

INDICATIONS & USAGE SECTION

For the temporarily relief of minor aches and muscle pains associated with arthritis,
simple backache, strains, muscle soreness and stiffness.

WARNINGS SECTION

• Only for external use. Use only as directed. Read and follow all directions and
warnings on this label.
• Do not use: on open wounds, cuts, damaged or infected skin as well as in the
eyes, mouth, genitals, or any other mucous membranes.
• Do not cover with bandage.
• Keep out of reach of children. Consult physician for children under 12.
• Consult your physician: if pregnant or pain persists or worsens or if you
experience signs of skin injury such as pain, swelling, or blistering where product
was applied or if symptoms persist for more than 7 days or clear up and occur
again within a few days.
• If swallowed, get medical help or contact a Poison Control Center right away.

INSTRUCTIONS FOR USE SECTION

• Clean and dry the affected area

• Open pouch and remove one patch
• Remove any protective film and apply directly to affected area of pain
• Wash hands with soap and water after applying patch
• Reseal pouch containing unused patches after each use

INACTIVE INGREDIENT SECTION

Methacrylic acid, ethylhexyl acrylate, bentonite, sodium stearate

OTC - DO NOT USE SECTION

on open wounds, cuts, damaged or infected skin as well as in the
eyes, mouth, genitals, or any other mucous membranes.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Consult physician for children under 12.

WARNINGS SECTION

  • Only for external use. Use only as directed. Read and follow all directions and

warnings on this label.
• Do not use: on open wounds, cuts, damaged or infected skin as well as in the
eyes, mouth, genitals, or any other mucous membranes.
• Do not cover with bandage.
• Keep out of reach of children. Consult physician for children under 12.
• Consult your physician: if pregnant or pain persists or worsens or if you
experience signs of skin injury such as pain, swelling, or blistering where product
was applied or if symptoms persist for more than 7 days or clear up and occur
again within a few days.
• If swallowed, get medical help or contact a Poison Control Center right away.

OVERDOSAGE SECTION

In Case of Ingestion or Overdose, get medical help or contact a Poison Control
Center (800-222-1222) right away.

DOSAGE & ADMINISTRATION SECTION

Adults and children 12 years and over: Apply patch to affected area 1 to 2 times
daily or as directed.

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Manufactured for : SOLA Pharmaceuticals

655 Highlandia Dr. Ste B

Baton Rouge, LA 70810



Store in a dry, cool place



For Comments or Questions, call 866-747-7365

LenzaPro Patch

Topical Pain Patch

for long lasting relief



NDC 70512-011-15



Qty: 15 Articulated Patches

(5 per Resealable Pouch) x 3

LenzaproLenzapro

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
70512-011-15EA - Each70512-011bdc2d70b-cf3e-44e4-ad4b-44b07c5a8cb212018-04-19

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 8 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
70512-01170512-011-15

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 6 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
efcec631-1ed8-4c4c-e053-2995a90a8ed8661ef396-0b38-6e1a-e053-2a91aa0a83522022-12-14WarningsExact identifier
spl set id: 661ef396-0b38-6e1a-e053-2a91aa0a8352

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.